期刊文献+

新生儿乙型肝炎疫苗低剂量免疫策略(隆安模式)远期效果评价 被引量:6

Long term Effectiveness of Low dose Strategy of Hepatitis B Vaccination Integrated with EPI Program
下载PDF
导出
摘要 采用整群抽样方法,选择了1018名1~7岁新生儿期接种3针10μg乙型肝炎血源疫苗免疫的儿童,检测HBsAg、抗BHs和抗HBc,以评价乙肝疫苗纳入儿童计划免疫,实施低剂量免疫策略7年后的效果。结果显示HBsAg阳性率为2.0%,与1985年该免疫计划实施前儿童HBsAg阳性率12.7%比较,疫苗保护率为85.0%,保护率从免疫后1~2年的82.0%逐年上升为免疫后7年的96.4%;抗HBs阳性率为79.7%,保护性抗体阳性率为54.2%;两者从免疫后1~2年的91.8%和75.0%明显下降为免疫后第7年的73.7%和48.2%;抗HBc阳性率为3.0%,显著低于免疫前的18.4%。结果说明低剂量免疫策略控制乙肝是成功的,实施7年后是否需加强免疫有待进一步观察。 A 7 year cross sectional follow up study was conducted to evaluate the long term effectiveness of a model HB immunization integrated with EPI program (low dose strategy) in Long An County of China in 1994.A sample of 1018 children aged 1 ̄7 years,who received 3 dosage of 10μg HB vaccine in infancy starting from 1987,were selected to test HBsAg,Anti HBs and Anti HBc.Of 1018 children,HBsAg positive rate was 2.0%,and effectiveness was 85.0%,compared with 12.7% of the baseline survey in 1985.The increase of effectiveness was from 82.0% at 1 ̄2 years to 96.4% at 7 years after infancy immunization.The Anti HBs positive rate was 79.7%,and the protective anti HBs positive rate was 54.2%,and the decrases for both rates ranged from 91.8% and 75.0% at 1 ̄2 years to 73.7% and 48.2% at 7 years after first dosages vaccination.Anti HBc positive rate was 3.0%, significantly lower than 18.4% of the baseline survey.The results showed that the low dose strategy was successful,and that need for vaccination against HB was not demonstrated in Long An County at 7 year after initial immunization.
出处 《中国公共卫生学报》 1997年第2期65-67,共3页
基金 美国中华医学基金
关键词 乙型肝炎 低剂量 免疫接种 远期效果 新生儿 Hepafifis B\ Long term effectiveness\ Low dose immunization integrated
  • 相关文献

参考文献3

  • 1徐志一,病毒学报,1991年,7卷,增刊,48页
  • 2邢玉兰,中华流行病学杂志,1991年,12卷,特刊9期,20页
  • 3徐志一,上海医学,1989年,1卷,2期,24页

同被引文献38

  • 1庄辉.乙型肝炎流行病学研究进展[J].国外医学(流行病学.传染病学分册),2004,31(3):133-135. 被引量:149
  • 2刘崇柏,苏崇鳌.乙型肝炎疫苗免疫及存在的问题[J].中国计划免疫,2004,10(3):159-162. 被引量:63
  • 3李雪翔,邬嘉生,刘建福,徐建兴,肖亮明,谢广中,刘德堂,王佐沂,熊素英,杨心乐,张谋鸿,杜立效,赵世立.小学生接种乙型肝炎血源疫苗后七年效果观察[J].中华预防医学杂志,1996,30(3):151-153. 被引量:20
  • 4[4]Hilton Whittle,Shabbar Jaffar,Michael Wansbrough,et al.Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children[J].BMJ,2002,325:569.
  • 5[1]Hadler SC, Judson FN, O' Malley PM, et al. Studies of hepatitis B vaccine in homosexual men [A]. In:Progress in hepatitis B immunization [M]. Colloques INSERM/John Libbey Eurotext Ltd. London. Paris 1990,194: 165
  • 6[2]Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan [J]. JAMA, 1996; 276 (11): 906
  • 7[3]Tabor E,Cairns J, Robert J, et al. Nine-year follow-up study of a plasma-derived hepatitis B vaccine in a rural Africa setting[J]. J Med Virol,1993;40: 204
  • 8[4]Wainwright RB,Bulkow LR, Parkinson AJ, et al. Pro-tection provided by hepatitis B vaccine in a Yuppies Es-kimo population: result of a 10-year study[J]. J Infect Dis, 1997,175:674
  • 9[6]West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination [J]. Vaccine, 1996, 14(11): 1019
  • 10[7]Coursaget P,Leboulleux D,Soumare M, et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants[J]. J Hepatol, 1994,21: 250

引证文献6

二级引证文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部